Price movement over the last 24 hours
Agilent Technologies Inc vs Vanguard High Dividend Yield ETF — how do they compare? Agilent Technologies Inc trades at $128.41 (market cap $37.04B), while Vanguard High Dividend Yield ETF trades at $160.17. The key difference: Agilent Technologies Inc pays a 0.78% dividend while Vanguard High Dividend Yield ETF pays none, and Vanguard High Dividend Yield ETF is trading nearer its 52-week high, Agilent Technologies Inc nearer its low. Which is the better fit depends on your goals.
| A | VYM | |
|---|---|---|
Market Cap | $37.04B | — |
Sector | Health | — |
52-Week High | $157.20 | $161.17 |
52-Week Low | $110.24 | $132.90 |
Enterprise Value | $38.59B | — |
Dividend Yield | 0.78% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $131.14, up 0.34% on the day, with a bearish technical signal but strong analyst support. The stock shows solid profitability with a net margin of 19.55% and ROE of 21.33%, supported by recent earnings beats. Recent acquisitions like Biocare Medical highlight growth initiatives, while cash flow trends remain positive. Valuation ratios such as P/E of 26.22 are elevated but align with quality growth expectations.
The outlook is positive given analyst consensus with a $154.90 price target and 77.5% buy ratings. Risks include execution of acquisitions and macroeconomic pressures on life sciences spending. The stock offers growth potential from AI-driven product launches, though technical resistance near $132 may cap near-term gains.
VYM trades at $160.14, up 0.41% with a bullish technical outlook supported by moving averages. The ETF focuses on high dividend yield stocks, offering investors steady income through quarterly distributions. Recent news highlights strong investor interest in dividend ETFs for retirement income, with VYM being frequently compared to peers like VIG and SCHD for its diversification and low 0.04% expense ratio.
VYM presents a compelling income-focused investment with stable technical momentum, though RSI levels suggest potential near-term consolidation. The fund's broad diversification across 618 stocks provides resilience, but investors should monitor sector concentration risks and interest rate sensitivity that could impact dividend sustainability.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →The advisor employs an indexing investment approach designed to track the performance of the index, which consists of common stocks of companies that pay dividends that generally are higher than average. The advisor attempts to replicate the target index by investing all, or substantially all, of the fund's assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.
Read more on VYM →